164 related articles for article (PubMed ID: 31836496)
21. Human papillomavirus type 16 E5-mediated upregulation of Met in human keratinocytes.
Scott ML; Coleman DT; Kelly KC; Carroll JL; Woodby B; Songock WK; Cardelli JA; Bodily JM
Virology; 2018 Jun; 519():1-11. PubMed ID: 29609071
[TBL] [Abstract][Full Text] [Related]
22. Evasion of host immune defenses by human papillomavirus.
Westrich JA; Warren CJ; Pyeon D
Virus Res; 2017 Mar; 231():21-33. PubMed ID: 27890631
[TBL] [Abstract][Full Text] [Related]
23. E5 proteins of human papillomavirus types 11 and 16 transactivate the c-fos promoter through the NF1 binding element.
Chen SL; Lin YK; Li LY; Tsao YP; Lo HY; Wang WB; Tsai TC
J Virol; 1996 Dec; 70(12):8558-63. PubMed ID: 8970980
[TBL] [Abstract][Full Text] [Related]
24. Involvement of Brd4 in different steps of the papillomavirus life cycle.
Iftner T; Haedicke-Jarboui J; Wu SY; Chiang CM
Virus Res; 2017 Mar; 231():76-82. PubMed ID: 27965149
[TBL] [Abstract][Full Text] [Related]
25. E5 protein of human papillomavirus type 16 protects human foreskin keratinocytes from UV B-irradiation-induced apoptosis.
Zhang B; Spandau DF; Roman A
J Virol; 2002 Jan; 76(1):220-31. PubMed ID: 11739687
[TBL] [Abstract][Full Text] [Related]
26. Binding of human papillomavirus 16 E5 to the 16 kDa subunit c (proteolipid) of the vacuolar H+-ATPase can be dissociated from the E5-mediated epidermal growth factor receptor overactivation.
Rodríguez MI; Finbow ME; Alonso A
Oncogene; 2000 Aug; 19(33):3727-32. PubMed ID: 10949926
[TBL] [Abstract][Full Text] [Related]
27. hrHPV E5 oncoprotein: immune evasion and related immunotherapies.
de Freitas AC; de Oliveira THA; Barros MR; Venuti A
J Exp Clin Cancer Res; 2017 May; 36(1):71. PubMed ID: 28545552
[TBL] [Abstract][Full Text] [Related]
28. Animal models of papillomavirus pathogenesis.
Campo MS
Virus Res; 2002 Nov; 89(2):249-61. PubMed ID: 12445664
[TBL] [Abstract][Full Text] [Related]
29. The human papillomavirus type 16 E7 oncogene is required for the productive stage of the viral life cycle.
Flores ER; Allen-Hoffmann BL; Lee D; Lambert PF
J Virol; 2000 Jul; 74(14):6622-31. PubMed ID: 10864676
[TBL] [Abstract][Full Text] [Related]
30. YIP1 family member 4 (YIPF4) is a novel cellular binding partner of the papillomavirus E5 proteins.
Müller M; Wasson CW; Bhatia R; Boxall S; Millan D; Goh GY; Haas J; Stonehouse NJ; Macdonald A
Sci Rep; 2015 Aug; 5():12523. PubMed ID: 26235900
[TBL] [Abstract][Full Text] [Related]
31. Human papillomavirus molecular biology and disease association.
Doorbar J; Egawa N; Griffin H; Kranjec C; Murakami I
Rev Med Virol; 2015 Mar; 25 Suppl 1(Suppl Suppl 1):2-23. PubMed ID: 25752814
[TBL] [Abstract][Full Text] [Related]
32. Down-regulation of microRNA-146a is associated with high-risk human papillomavirus infection and epidermal growth factor receptor overexpression in penile squamous cell carcinoma.
Peta E; Cappellesso R; Masi G; Sinigaglia A; Trevisan M; Grassi A; Di Camillo B; Vassarotto E; Fassina A; Palù G; Barzon L
Hum Pathol; 2017 Mar; 61():33-40. PubMed ID: 27818285
[TBL] [Abstract][Full Text] [Related]
33. Control of viral replication and transcription by the papillomavirus E8^E2 protein.
Dreer M; van de Poel S; Stubenrauch F
Virus Res; 2017 Mar; 231():96-102. PubMed ID: 27825778
[TBL] [Abstract][Full Text] [Related]
34. E5HPV16 mRNA EXPRESSION PATTERN ANALYSIS IN PATIENTS WITH CERVICAL LESIONS IN VIRAL STATUS CONTEXT.
Iancu IV; Pleşa A; Botezatu A; Huică I; Stănescu AD; Socolov D; Anton G
Roum Arch Microbiol Immunol; 2015; 74(1-2):33-9. PubMed ID: 26727852
[TBL] [Abstract][Full Text] [Related]
35. E5 can be expressed in anal cancer and leads to epidermal growth factor receptor-induced invasion in a human papillomavirus 16-transformed anal epithelial cell line.
Wechsler EI; Tugizov S; Herrera R; Da Costa M; Palefsky JM
J Gen Virol; 2018 May; 99(5):631-644. PubMed ID: 29624161
[TBL] [Abstract][Full Text] [Related]
36. Are transforming properties of the bovine papillomavirus E5 protein shared by E5 from high-risk human papillomavirus type 16?
Suprynowicz FA; Disbrow GL; Simic V; Schlegel R
Virology; 2005 Feb; 332(1):102-13. PubMed ID: 15661144
[TBL] [Abstract][Full Text] [Related]
37. Effects of human papillomavirus type 16 E5 deletion mutants on epithelial morphology: functional characterization of each transmembrane domain.
Barbaresi S; Cortese MS; Quinn J; Ashrafi GH; Graham SV; Campo MS
J Gen Virol; 2010 Feb; 91(Pt 2):521-30. PubMed ID: 19812262
[TBL] [Abstract][Full Text] [Related]
38. Codon optimization of the HPV-16 E5 gene enhances protein expression.
Disbrow GL; Sunitha I; Baker CC; Hanover J; Schlegel R
Virology; 2003 Jun; 311(1):105-14. PubMed ID: 12832208
[TBL] [Abstract][Full Text] [Related]
39. Human papillomavirus type 31 E5 protein supports cell cycle progression and activates late viral functions upon epithelial differentiation.
Fehrmann F; Klumpp DJ; Laimins LA
J Virol; 2003 Mar; 77(5):2819-31. PubMed ID: 12584305
[TBL] [Abstract][Full Text] [Related]
40. Down-regulation of MHC class I is a property common to papillomavirus E5 proteins.
Ashrafi GH; Brown DR; Fife KH; Campo MS
Virus Res; 2006 Sep; 120(1-2):208-11. PubMed ID: 16780984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
